🗓️ Published: May 28, 2025
✍️ By: Prashant Marathe
Tags: CARE Ratings, Q4FY25 results, Singapore NDR, Institutional Investor Meeting, CARE Share Price, Rating Agencies India, B&K Securities, SEBI LODR Compliance
📌 At a Glance
CARE Ratings Ltd (NSE: CARERATING) is all set for a two-day Non-Deal Roadshow (NDR) in Singapore on June 24–25, 2025, organised by B&K Securities. The management will meet institutional investors in a 1×1 and group format. No UPSI will be discussed, they say. But can they convince the Street with only public info and PowerPoint slides?
Meanwhile, the stock closed at ₹1,676, down 1.73% today, in line with the broader midcap selloff.
🏦 What’s the Update?
📢 CARE Ratings filed an exchange intimation on May 28, 2025, under Regulation 30 of SEBI LODR, saying:
- They’ll meet investors in Singapore
- It’s a Non-Deal Roadshow, meaning no fundraising pitch—just goodwill building
- Discussions will stick to publicly available information
- Investor Presentation already uploaded here:
🔗 Q4 FY25 Investor Deck
✈️ Why Singapore?
Let’s decode:
- Global interest in India’s infra & finance stories is surging. With Bharat Ratings & ICRA also stepping up global investor connect, CARE doesn’t want to be left behind.
- Singapore = Asia’s fund capital, especially for midcap financials.
- CARE’s stock is up ~90% from its
